Novo Nordisk A/S ( NVO) - Key Metrics

NVO Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $17.73 $4.74 $12.47 $9.57
2026Q1 $21.79 $10.93 $5.42 $2.71
2025Q4 $17.79 $6.05 $1.71 -$8.14
2025Q3 $16.86 $4.50 $10.37 $6.90
2025Q2 $17.28 $5.96 $9.17 $5.51

NVO Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% 16.55
2026Q1 72.72% 5.44
2025Q4 0% 13.35
2025Q3 83.29% 19.61
2025Q2 0.66% 18.32

NVO Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 3.05% 0%
2026Q1 1.14% 3.34%
2025Q4 -2.52% 0%
2025Q3 1.96% 1.06%
2025Q2 1.26% 0.01%

NVO

Price: $46.93

52 week price:
34.58
64.16

Dividend Yield: 3.80%

5-year range yield:
0.74%
4.93%

Forward Dividend Yield: 2.48%

Payout Ratio: 24.32%

Payout Ratio Range:
0.01%
449.50%

Dividend Per Share: 1.16 USD

Earnings Per Share: 4.09 USD

P/E Ratio: 11.67

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: Denmark

Volume: 1.1 million

Ebitda: 1.9 billion

Market Capitalization: 209.1 billion

Average Dividend Frequency: 2

Years Paying Dividends: 45

DGR3: 29.57%

DGR5: 22.96%

DGR10: 20.32%

DGR20: 22.69%

Links: